Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With <i>ERBB2/HER2</i> -Negative Breast Cancer—The Evaluating Treatment With Neoadjuvant Abraxane (ETNA) Trial - Concepedia

Concepedia

Publication | Open Access

Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With <i>ERBB2/HER2</i> -Negative Breast Cancer—The Evaluating Treatment With Neoadjuvant Abraxane (ETNA) Trial

DOI Full Paper Access

153

Citations

18

References

2018

Year

Luca Gianni, Mauro Mansutti, Antonio Antón, Lourdes Calvo, Giancarlo Bisagni, Begoña Bermejo, Marc Thill, José Ignacio Chacón, Arlene Chan, Serafín Morales,

Abstract

clinicaltrials.gov Identifier: NCT01822314.

References

	Year	Citations

Page 1